A method for sorting colorectal cancer and advanced adenoma and use of the same
AssigneeINOGENIX Inc.
InventorsDa som HWANG, Hyo seok Yang
Life of this patent
Estimating the term…
Loading patent…
AssigneeINOGENIX Inc.
InventorsDa som HWANG, Hyo seok Yang
Estimating the term…
The present invention relates to a detecting method for colorectal cancer and advanced adenoma group, comprising measuring the relative expression level of MKi67, KRT19, EpCAM, TYMS, PPARG, MCAM, ANKHD1-EIF4EBP3, SNAI2, MMP23B, FOXA2, NPTN, GPR15, TERT, VIM, and ERBB2 genes or proteins encoded by the genes in sample, wherein if the MKi67, KRT19 and EpCAM genes are expressed higher than other genes, it is judged as a normal group, if the TYMS, PPARG, MCAM, and ANKHD1-EIF4EBP3 genes are expressed higher than other genes, it is judged as a colorectal cancer group, if the SNAI2, MMP23B, and FOXA2 genes are expressed higher than other genes, it is judged as an advanced adenoma group or colorectal cancer group, if the NPTN, GPR15, TERT, VIM and ERBB2 genes are expressed higher than other genes, it is judged as an advanced adenoma group.
A method for increasing the likelihood of making a positive colorectal cancer diagnosis, comprising:
Dependencies are inferred from the claim text.